Aeon Biopharma (AEON) said late Monday it appointed Robert Bancroft as chief executive officer, starting April 29.
Bancroft most recently served as general manager of the therapeutics business at Revance Therapeutics.
Jost Fisher will step down as interim president and CEO but will remain chairman of the board, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.